Has the world's leading science journal abandoned the ideal of human dignity?
An ethical development could make embryonic stem cell research obsolete and derail plans for California's $3 billion institute.
As forecast, therapeutic cloning is well and truly on the skids. But how did it happen so quickly?
Two big stories this week could signal the end of therapeutic cloning.
The possibility of creating a bewildering variety of human-animal combinations requires profound ethical reflection.
An exclusive interview with an Iowa scientist who is promoting adult stem cell research.
Britain's fertility regulator has just approved the creation of human-animal embryos for research. What's next?
After years of urging the public and governments to support the destruction of embryos, scientists may have led them up a blind alley.
The world's leading medical and science journals have taken to dabbling in politics.
In the US and Australia this week, doors were opened to therapeutic cloning. In a few years' time, voters may come to regret it.
Using TV ads to present the truth about embryo research is an uphill slog.
There was good news and bad news about human embryo research last week. As usual, everyone ignored the good news.
In November Missouri voters will decide whether their state should legalise therapeutic cloning. Are they being told the whole truth?
Harvard University has given the cause of therapeutic cloning the backing of its immense prestige. A stem cell scientist tells MercatorNet that this is based on inflated hopes and bad science.
Revelations of fraud and unethical conduct in the world’s leading embryonic stem cell lab could lead to a rethink of stem cell ethics.
Page 1 of 2 : 1 2 >
free updates
Email
RSS | Atom | 
del.icio.us | Privacy Policy | 
3
